Helena A. Yu

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis

Nature Communications(2023)10.1038/s41467-023-40793-x

Top 16%

1.3DataRank

Top 16%63 citations

Henry Walch, Kathryn R. Tringale, Jordan Eichholz, Brandon S. Imber, Harish N. Vasudevan +12 more

Papers

Driven by 44 papers — median percentile 84. Top paper: “The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance”.

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Nature Genetics(2023)10.1038/s41588-023-01592-8

N/A

1.9DataRank · unranked

88 citations

Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey +80 more

Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis

Nature Communications(2023)10.1038/s41467-023-40793-x

Top 16%

1.3DataRank

Top 16%63 citations

Henry Walch, Kathryn R. Tringale, Jordan Eichholz, Brandon S. Imber, Harish N. Vasudevan +12 more

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-23912-4

N/A

1.1DataRank · unranked

34 citations

Adam J. Schoenfeld, Alex Makhnin, Yosef Y. Tobi, Yuli Wang, Heidie Frisco Cabanos +10 more

COVID-19 in patients with lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.06.007

N/A

0.840DataRank · unranked

270 citations

Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chai Bandlamudi +26 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0.792DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5

N/A

0.782DataRank · unranked

183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C–Mutant Non–Small Cell Lung Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4023

N/A

0.725DataRank · unranked

125 citations

Hira Rizvi, Andrew J. Plodkowski, Matthew D. Hellmann, Andrea Knežević, Glenn Heller +8 more

Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.022

N/A

0.695DataRank · unranked

102 citations

Antonio Marra, Jane Sze Yin Sui, Jessica Flynn, Soo‐Ryum Yang, Christina J. Falcon +14 more

Chromothripsis-Mediated Small Cell Lung Carcinoma

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0286

N/A

0.584DataRank · unranked

48 citations

Sam E. Tischfield, Christopher A. Febres‐Aldana, Jake June-Koo Lee, Jason C. Chang, Benjamin Herzberg +37 more

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012

N/A

0.571DataRank · unranked

44 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3497

N/A

0.564DataRank · unranked

42 citations

Jacqueline V. Aredo, Jacqueline H. Starrett, Paul Stockhammer, Iris K. van Alderwerelt van Rosenburgh, Anna Wurtz +16 more

CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation

Signal Transduction and Targeted Therapy(2024)10.1038/s41392-024-01908-y

N/A

0.489DataRank · unranked

25 citations

Kenta Kawasaki, Esther Redín, Fathema Uddin, Swanand Rakhade, Vidushi Durani +28 more

Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3981

N/A

0.472DataRank · unranked

12 citations

Soo‐Ryum Yang, Jessica J. Tao, Antoine Desîlets, Eli L. Diamond, Clare Wilhelm +18 more

Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100256

N/A

0.396DataRank · unranked

13 citations

Eusebio Manchado, Matthew J. Bott, Linda S. Ahn, Yosef Y. Tobi, Andy Ai Ni +14 more

Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2022)10.1016/j.jtcvs.2022.10.056

N/A

0.345DataRank · unranked

9 citations

Junting Zheng, Kay See Tan, Corinne C. Liu, Bernard J. Park, Gaetano Rocco +12 more

Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21098

N/A

0.330DataRank · unranked

8 citations

Debra A. Goldman, Sabrina T. Lin, Darren J. Buonocore, Jianjiong Gao, Jason C. Chang +15 more

Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.010

N/A

0.269DataRank · unranked

5 citations

Rohit Thummalapalli, Christopher A. Febres‐Aldana, Daniel M. Muldoon, Christina J. Falcon, Amanda Pupo +18 more

Genomic landscape of MTAP deletions and association with EGFR alterations in NSCLC.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.8599

N/A

0.208DataRank · unranked

3 citations

Daniel M. Muldoon, Christopher A. Febres‐Aldana, Christina J. Falcon, Amanda Pupo, Chaitanya Bandlamudi +6 more

Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.10.012

N/A

0.208DataRank · unranked

3 citations

Jake June-Koo Lee, Noura J. Choudhury, Angela B. Hui, Mark Jeng, Jennifer Zheng +20 more

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR -Mutant Lung Adenocarcinomas

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3484

N/A

0.165DataRank · unranked

2 citations

Alex Makhnin, Khadeja A. Moses, Linda S. Ahn, Isabel R. Preeshagul, Afsheen N. Iqbal +9 more

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

JCO Precision Oncology(2024)10.1200/po.23.00454

N/A

0.104DataRank · unranked

1 citations

Zihe Song, Helena A. Yu, Lecia V. Sequist, Christine M. Lovly, Edith P. Mitchell +17 more

Signatures of early plasticity in the histological transformation of lung cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.8042

N/A

0.104DataRank · unranked

1 citations

Monica F. Chen, Àlvaro Quintanal-Villalonga, Amin H. Sabet, Parvathy Manoj, Ojasvi Chaudhary +12 more

Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells

Science Translational Medicine(2022)10.1126/scitranslmed.abc7480

N/A

0DataRank · unranked

45 citations

Min Lu, Hazel X. Ang, Ryan S. Soderquist, Christine E. Eyler, Haley M. Hutchinson +12 more

1MO Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1997

N/A

0DataRank · unranked

0 citations

Hirokazu Taniguchi, Yu Zhan, Maysun Hasan, Shweta S. Chavan, Fathema Uddin +15 more

Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers

Science Translational Medicine(2023)10.1126/scitranslmed.adf7006

N/A

0DataRank · unranked

44 citations

Vidushi Durani, Amin H. Sabet, Esther Redín, Kenta Kawasaki, Moniquetta Shafer +20 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9009

N/A

0DataRank · unranked

19 citations

Emily S. Lebow, Yonina R. Murciano‐Goroff, Gowtham Jayakumaran, Ronglai Shen, A. Rose Brannon +15 more

Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100607

N/A

0DataRank · unranked

9 citations

Ryka Sehgal, Rachel Saganty, Anne S. Reiner, Ahmet Turan Ilıca, Emily Miao +8 more

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0DataRank · unranked

293 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

Clinical and genomic landscape of EGFR-mutant lung cancers (LCs) with squamous and adenosquamous differentiation.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9129

N/A

0DataRank · unranked

0 citations

Christina J. Falcon, Allison L. Richards, Alexandria Dymun, Paul K. Paik, Rania G. Aly +5 more

Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasis

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab181

N/A

0DataRank · unranked

30 citations

Adrienne Boire, Robert J. Young, Yoshiya Yamada, Suzanne L. Wolden, Helena A. Yu +9 more

Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01186-z

N/A

0DataRank · unranked

93 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +25 more

Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.01488

N/A

0DataRank · unranked

35 citations

Meagan Montesion, Smruthy Sivakumar, Caryn Hale, Anita S. Bowman, Ayyüce Begüm Bektaş +29 more

Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis

Cancer Cell(2021)10.1016/j.ccell.2021.07.006

N/A

0DataRank · unranked

174 citations

Helena A. Yu, Shaoyuan Yang, Song Han, S. Duygu Selçuklu, Kwanghee Kim +15 more

Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01846-4

N/A

0DataRank · unranked

20 citations

Alexandra Miller, Bridget M Holle, Justin Jee, Siyang Liu, Dara S. Ross +27 more

Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1863

N/A

0DataRank · unranked

181 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +31 more

Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.02.408476

N/A

0DataRank · unranked

24 citations

Hirozaku Taniguchi, Yingqian A. Zhan, Maysun Hasan, Fanli Meng, Fathema Uddin +23 more

Effect of CDC7 inhibition and MYC degradation on neuroendocrine transformation in the lung and prostate cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.e20105

N/A

0DataRank · unranked

0 citations

Kenta Kawasaki, Esther Redín, Swanand Rakhade, Vidushi Durani, Amin Sabet +15 more

Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection

Nature Medicine(2025)10.1038/s41591-025-03780-x

N/A

0DataRank · unranked

45 citations

Neeraj Kumar, Swaraj Nanda, Siddharth Singi, Eugene Fluder, Ricky Kwan +21 more

Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases

Annals of Oncology(2025)10.1016/j.annonc.2025.06.001

N/A

0DataRank · unranked

9 citations

Mark Jeng, S Tischfield, J.S.Y. Sui, Dmitry Nemirovsky, Glenn Heller +9 more

Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung Cancers

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.09.019

N/A

0DataRank · unranked

19 citations

Michael Offin, Daisuke Kubota, Helena A. Yu, Clare Wilhelm, Shinichi Toyooka +4 more

Clinical trial of proton craniospinal irradiation for leptomeningeal metastases

Neuro-Oncology(2020)10.1093/neuonc/noaa152

N/A

0DataRank · unranked

101 citations

N. Ari Wijetunga, Josh Yamada, Suzanne L. Wolden, Michelle Mehallow, Debra A. Goldman +16 more

Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9100

N/A

0DataRank · unranked

0 citations

Antonio Marra, Soo‐Ryum Yang, Christina J. Falcon, Glenn Heller, Mark G. Kris +4 more

Responsiveness of different MET tumour alterations to type I and type II MET inhibitors

Clinical and Translational Medicine(2025)10.1002/ctm2.70338

N/A

0DataRank · unranked

3 citations

Valentina Foglizzo, Jason Chang, Natasha Rekhtman, Ann Elizabeth Sisk, Jamie Gibson +20 more

Efficacy of osimertinib in patients with EGFR mutant lung cancer harboring the uncommon exon 19 deletion, L747_A750>P.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21112

N/A

0DataRank · unranked

0 citations

Jacqueline V. Aredo, Jacqueline H. Starrett, Anna Wurtz, Zofia Piotrowska, Andrew J. Piper‐Vallillo +13 more

Helena A. Yu

Indexed papers

Top data-sharing exemplar

Papers